Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000019617-08-000218
Filing Date
2008-02-11
Accepted
2008-02-11 17:18:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 LIGAND PHARM INC. ligand1231f.htm SC 13G 33833
  Complete submission text file 0000019617-08-000218.txt   36068
Mailing Address 270 PARK AVENUE NEW YORK NY 10017
Business Address 270 PARK AVE 39TH FL NEW YORK NY 10017 2122706000
J P MORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

EIN.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6021 National Commercial Banks

Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-43329 | Film No.: 08594605
SIC: 2834 Pharmaceutical Preparations